Mycoplus Co., Ltd.

By developing biological control agent using Entomopahtogenci fungi (Fungi also known as Winter Worm, summer plant), Mycoplus made it possible for farmers to grow high-quality agricultural products without chemicals. Moreover, Mycoplus uses some 400 strains of indigenous Eutomopathogenic fungi isolated in Korea to ceaselessly develop natural medical products.

Approximately 10 items, including an ASTOPY set that's proven effective in improving Atopic Dermatitis within
7 days, are either being developed or are on the way to being patented. ASTOPY cosmetic set contains MP108, which is an extract from Cordyceps effective in fighting Atopic and contact dermatitis.

In July 2001, Mycoplus was certified as a ventur
e company. In November 2003, Mycoplus received INNO-BIZ certificate (given to innovative small and medium size businesses) from the small and medium business administration of Korea.

Moreover, with its basis on the company mission and entomopath
ogenic fungi, Mycoplus has actively participated in creating educational documentary TV shows and contributed to spreading the information on the benefits of microorganism to the general public.

Mycoplus began as a small company constituted by t
hree members ready to challenge. It promises to not forget its initial goal to become a competitive, trustworthy company that contributes to human welfare by investing and researching for the benefit of human health and life. It also promises to be a customer and shareholder-oriented company.